Domov › Melanóm › Kalifornia › San Francisco
Klinické štúdie Melanóm v meste San Francisco, CA
22 štúdií pre Melanóm hľadá účastníkov v zariadeniach v meste San Francisco a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Prebieha náborFáza 2
- UCSF Medical Center at Mission Bay ( Site 4044), San Francisco
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Prebieha náborFáza 3
- University of California San Francisco (UCSF), San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of California, San Francisco, San Francisco
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Prebieha náborFáza 2
- Local Institution - 0096, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of California-San Fransisco, San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Prebieha náborFáza 1
- University of California San Francisco, San Francisco
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Prebieha náborFáza 1/2
- University of California San Francisco, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- UCSF Medical Center-Mission Bay, San Francisco
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Prebieha náborFáza 2
- University of California, San Francisco, San Francisco
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Prebieha náborFáza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Prebieha náborFáza 3
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Prebieha nábor
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Prebieha náborFáza 1/2
- University of California San Francisco (UCSF), San Francisco
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Prebieha náborFáza 2/3
- UCSF, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Prebieha náborFáza 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Kaiser Permanente-San Francisco, San Francisco
ACTengine® IMA203 Combined With mRNA-4203
Prebieha náborFáza 1
- University of California San Francisco, San Francisco
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Prebieha náborFáza 2
- California Pacific Medical Center - Sutter Health, San Francisco
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
Prebieha náborObservačná štúdia
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Prebieha náborFáza 2
- University of California, San Francisco (UCSF), San Francisco
Štúdie Melanóm v iných mestách
- Houston, TX59 štúdií
- New York City, NY38 štúdií
- Los Angeles, CA34 štúdií
- Nashville, TN33 štúdií
- Pittsburgh, PA31 štúdií
- Boston, MA26 štúdií
- Philadelphia, PA23 štúdií
- Atlanta, GA21 štúdií
- Durham, NC21 štúdií
- St. Louis, MO21 štúdií
- Columbus, OH21 štúdií
- Salt Lake City, UT21 štúdií
Iné štúdie v San Francisco
- Rakovina prostaty45 štúdií
- Rakovina prsníka43 štúdií
- Nemalobunkový karcinóm pľúc36 štúdií
- Rakovina (všetky typy)35 štúdií
- Srdcové zlyhanie29 štúdií
- Metastatická rakovina28 štúdií
- Rakovina pľúc23 štúdií
- Rakovina pankreasu20 štúdií
- Rakovina vaječníkov19 štúdií
- Kolorektálny karcinóm18 štúdií
- Kardiovaskulárne ochorenia18 štúdií
- Glioblastóm17 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.